Results 221 to 230 of about 227,821 (350)
This study shows that human iPSC‐derived endothelial cells acquire a functional blood–brain barrier phenotype when co‐cultured with brain pericytes and stimulated with CHIR‐99021, a Wnt/β‐catenin activator. This model recapitulates key barrier properties, inflammatory responses, and transcriptomic features of the native human BBB, offering new ...
Henrique Nogueira Pinto +12 more
wiley +1 more source
Role of human umbilical cord mesenchymal stem cells in diabetic kidney disease. [PDF]
Liu Y, Shan XQ, Li YJ, Gao WL, Zhao L.
europepmc +1 more source
Violence, Volition, and Volatility: The Embodied Subjectivity of Women in Cults
This paper explores the embodied experience of 25 women who are former cult members. By delving into the stories of three protagonists, we examine how these women engaged with and possibly redefined the cult's socially constructed notion of womanhood.
Shirly Bar‐Lev, Michal Morag
wiley +1 more source
The impact of true knot of umbilical cord on obstetric outcomes-true or not? [PDF]
Porat S +5 more
europepmc +1 more source
Outcome of Umbilical Cord Prolapse in A Tertiary Health Centre in Northwestern Nigeria
Burodo Ahmed Tanko +6 more
openalex +1 more source
ABSTRACT Objective Complete hydatidiform mole and coexisting normal fetus (CHMCF) is a rare condition for which there is significant heterogeneity in diagnosis, counseling and management of complications. The objective of this study was to summarize the prevalence of clinical outcomes in reported cases of CHMCF.
N. Salmeri +8 more
wiley +1 more source
Umbilical Cord Blood pH Level, Apgar Score, and Attention-Deficit/Hyperactivity Disorder.
Pedersen MV +4 more
europepmc +1 more source
South African midwives' knowledge of the benefits of delayed umbilical cord clamping. [PDF]
Shosha A +2 more
europepmc +1 more source
Fetoscopic laser ablation vs standard management for Type‐II and Type‐III vasa previa
ABSTRACT Objective The standard management (SM) for vasa previa (VP) includes antepartum inpatient admission at 28–32 weeks' gestation followed by Cesarean delivery at 34–37 weeks. Case reports and case series have reported on fetoscopic laser ablation (FLA) as an alternative management approach for Types‐II and ‐III VP.
S. Backley +11 more
wiley +1 more source

